Vignette: You have a patient with a TSH of 0.27 and normal T3 and T4 levels. How would you handle this patient?
-Dx: likely 2/2 central hypothyroidism, nonthyroidal illness, hyperthyroidism recovery, excessive ingestion biotin, etc
-Pt is asx at this point.
-Will f/u closely because about 15% pts progress to overt hyperthyroidism in 2yrs. Also, there is an increased risk of CAD, AF, Osteoporosis.
-Will recheck labs in 3-6 mo to document resolution vs. persistent. If persistent and TSH < 0.1, will consider treatment and RAIU.
-If TSH between 0.1-0.5, we will consider treatment when elderly, symptomatic, or with CV disease.
-Definition: Subclinical Hyperthyroidism = normal T4 & T3 concentrations in the presence of low TSH
-Most common causes of subclinical hyperthyroidism are treatment with T4 (exogenous) and autonomously functioning thyroid adenomas and multinodular goiters (endogenous).
Will get the following labs/studies:
- Serum TSH (initial)
- Repeat TSH and do free T4, T3 serum levels if initial TSH <0.5 to establish a diagnosis.
- Monitor: repeat TSH, T4, T3 in 1-3 months
- Radioactive iodine uptake
- Thyroid US to r/o nodules.
- Thyrotropin receptor antibodies (TRAb) or TSI confirms Graves
- Will any underlying condition as in overt hyperthyroidism
- Will evaluate and f/u for possible complications such as atrial fibrillation (older adults), decreases bone mineral density (post-menopausal women)
——————–
Subclinical hyperthyroidism is defined as normal serum free thyroxine (T4) and triiodothyronine (T3) in the setting of a subnormal Thyroid-Stimulating Hormone (<0.5 mU/L). Patients taking thyroid hormone replacement are at risk of developing subclinical hyperthyroidism, and up to 25% of patients on levothyroxine develop low serum TSH. Among other causes of endogenous subclinical hyperthyroidism, the most common are thyroid adenomas, multinodular goiters, and thyroiditis.
Ddx: Central hypothyroid, Nonthyroidal illness, Recovery from hyperthyroidism, Excessive biotin intake (artifactually low TSH), Shifting in TSH distribution in healthy patients (African descendants).
http://www.aafp.org/afp/2011/0415/p933.html